The National Quality Forum (NQF) is seeking public comments between now and June 25 at 6 p.m. ET on 12 cardiovascular measures submitted by the ACC for endorsement. Many of these 12 measures were developed through the joint ACC/American Heart Association (AHA) Task Force on Performance Measures.

The public comment period provides an opportunity for the cardiovascular community and other stakeholders to play an active role in the development of performance measures that could potentially have a direct impact on hospitals and facilities. The ACC has committed significant resources over the years in both developing and testing cardiovascular measures. The measures submitted meet key attributes of measurement and include:

1. NQF# 0133: In-Hospital Risk Adjusted Rate of Mortality for Patients Undergoing Percutaneous Coronary Intervention (PCI)
2. NQF# 0535: 30-Day All-Cause Risk-Standardized Mortality Rate Following PCI for Patients Without ST-Segment Elevation Myocardial Infarction (STEMI) and Without Cardiogenic Shock
3. NQF# 0536: 30-Day All-Cause Risk-Standardized Mortality Rate Following PCI for Patients With STEMI or Cardiogenic Shock
4. NQF# 0642: Cardiac Rehabilitation Patient Referral From an Inpatient Setting
5. NQF# 0643: Cardiac Rehabilitation Patient Referral From an Outpatient Setting (there was a measurement period adjustment request)
6. NQF# 0964: Therapy With Aspirin, P2Y12 Inhibitor, and Statin at Discharge Following PCI in Eligible Patients
7. NQF# 2377: Defect Free Care for Acute Myocardial Infarction
8. NQF# 2411: PCI: Comprehensive Documentation of Indications for PCI
9. NQF# 2452: PCI: Post-Procedural Optimal Medical Therapy
10. NQF# 2455: Heart Failure: Post-Discharge Appointment for Heart Failure Patients
11. NQF# 2450: Heart Failure: Symptom and Activity Assessment
12. NQF# 2459: In-Hospital Risk Adjusted Rate of Bleeding Events for Patients Undergoing PCI

Following the comment period, the NQF expert panel will review the comments and make their final recommendations to the NQF Board. Official endorsement from NQF would better ensure ACC and AHA developed measures would be included in key national public reporting and payment programs. While this process is lengthy, your support and comments are critical to ensuring ACC’s continued success at NQF. To this end we encourage you to submit comments via the NQF Web site by June 25. In order to comment on the measures, you must have an NQF login. If you do not have one, you can set one up here.

Keywords: Shock, Cardiogenic, Myocardial Infarction, Referral and Consultation, Documentation, Heart Failure, Percutaneous Coronary Intervention, Risk Adjustment

< Back to Listings